TY - JOUR T1 - Head and Neck Arteriovenous Malformations: Results of Ethanol Sclerotherapy JF - American Journal of Neuroradiology JO - Am. J. Neuroradiol. DO - 10.3174/ajnr.A3180 AU - J. Pekkola AU - K. Lappalainen AU - P. Vuola AU - T. Klockars AU - P. Salminen AU - A. Pitkäranta Y1 - 2012/07/05 UR - http://www.ajnr.org/content/early/2012/07/05/ajnr.A3180.abstract N2 - BACKGROUND AND PURPOSE: Peripheral AVM is a locally aggressive disease with a high tendency to recur; its treatment is complex, especially in the anatomically delicate head and neck area. Here, we report results of ethanol sclerotherapy for head and neck AVM and discuss its potential use for peripheral AVM. MATERIALS AND METHODS: We retrospectively assessed degree of AVM eradication, complications, and clinical or imaging signs of recurrence for 19 patients treated with ethanol sclerotherapy for head and neck AVM (1 intraosseous, 18 soft-tissue AVMs). RESULTS: Of the 19 patients, 11 had complete eradication of arteriovenous shunting at DSA, with 1 recurrence (mean follow-up 15 months), and for 7 patients, treatment is ongoing. During 59 treatment sessions, 12 patients experienced 14 complications, 1 leading to permanent functional damage. CONCLUSIONS: Ethanol sclerotherapy has potential for complete eradication of head and neck AVM with low recurrence within the first year after completion of treatment. Complete eradication may require several treatment sessions during which complications should be minimized with careful techniques. Abbreviations ECAexternal carotid arteryn-BCAn-butyl cyanoacrylatePVApolyvinyl alcohol particles ER -